March 14, 2017 / 11:38 AM / 5 months ago

BRIEF-Fortress Biotech appoints Lung Yam as CEO of Cyprium

March 14 (Reuters) - Fortress Biotech Inc-

* Fortress Biotech forms new subsidiary, Cyprium Therapeutics to develop novel therapies for menkes disease and related copper metabolism disorders

* Announced appointment of Lung S. Yam as chief executive officer of Cyprium Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below